{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:56:27Z","timestamp":1781218587485,"version":"3.54.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW Fortschr Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s15006-026-5908-9","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:02:09Z","timestamp":1781215329000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Persistierende Beschwerden: Psychosomatisch bedingt?","In-consultation functional assessment for persistent physical symptoms"],"prefix":"10.1007","volume":"168","author":[{"given":"Eik","family":"Niederlohmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"5908_CR5139","doi-asserted-by":"crossref","unstructured":"Roenneberg C et al. Functional somatic symptoms. Dtsch Arztebl Int. 2019;116:553-60","DOI":"10.3238\/arztebl.2019.0553"},{"key":"5908_CR5143","unstructured":"AWMF. Funktionelle K\u00f6rperbeschwerden. S3-Leitlinie, Registernr. 051-001, Version 2.0, ver\u00f6ffentlicht am 14.11.2018, g\u00fcltig bis 17.07.2023; Update seit 20.07.2023 im AWMF-Register angemeldet. Verf\u00fcgbar \u00fcber das AWMF-Register; abgerufen am 13.4.2026"},{"key":"5908_CR5216","doi-asserted-by":"crossref","unstructured":"Haller H et al. Somatoform disorders and medically unexplained symptoms in primary care: a systematic review and meta-analysis of prevalence. Dtsch Arztebl Int. 2015;112:279-87","DOI":"10.3238\/arztebl.2015.0279"},{"key":"5908_CR5153","doi-asserted-by":"crossref","unstructured":"L\u00f6we B et al. Persistent physical symptoms: definition, genesis, and management. Lancet. 2024;403:2649-62","DOI":"10.1016\/S0140-6736(24)00623-8"},{"key":"5908_CR5222","doi-asserted-by":"crossref","unstructured":"Jadhakhan F et al. Prevalence of medically unexplained symptoms in adults who are high users of healthcare services and magnitude of associated costs: a systematic review. BMJ Open. 2022;12:e059971","DOI":"10.1136\/bmjopen-2021-059971"},{"key":"5908_CR5232","doi-asserted-by":"crossref","unstructured":"Henningsen P et al. Management of functional somatic syndromes and bodily distress. Psychother Psychosom. 2018;87:12-31","DOI":"10.1159\/000484413"},{"key":"5908_CR5236","doi-asserted-by":"crossref","unstructured":"Burton C et al. Functional somatic disorders: discussion paper for a new common classification for research and clinical use. BMC Med. 2020;18:34","DOI":"10.1186\/s12916-020-1505-4"},{"key":"5908_CR5165","doi-asserted-by":"crossref","unstructured":"van Dessel N et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms in adults. Cochrane Database Syst Rev. 2014;CD011142","DOI":"10.1002\/14651858.CD011142"},{"key":"5908_CR5293","doi-asserted-by":"crossref","unstructured":"Swainston K et al. What psychological interventions are effective for the management of persistent physical symptoms (PPS)? A systematic review and meta-analysis. Br J Health Psychol. 2023;28:80-97","DOI":"10.1111\/bjhp.12613"},{"key":"5908_CR5169","doi-asserted-by":"crossref","unstructured":"Abbass A et al. Short-term psychodynamic psychotherapy for functional somatic disorders: a meta-analysis of randomized controlled trials. Psychother Psychosom. 2020;89:363-70","DOI":"10.1159\/000507738"},{"key":"5908_CR5254","unstructured":"Abbass A et al. Intensive short-term dynamic psychotherapy for functional somatic disorders: a scoping review. Clin Neuropsychiatry. 2025;22:111-20"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-026-5908-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15006-026-5908-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-026-5908-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:02:12Z","timestamp":1781215332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-026-5908-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5908"],"URL":"https:\/\/doi.org\/10.1007\/s15006-026-5908-9","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"12 June 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Der Autor erkl\u00e4rt, dass er sich bei der Erstellung des Beitrags von keinen wirtschaftlichen Interessen leiten lie\u00df. Er legt folgende potenzielle Interessenkonflikte offen: E. N. arbeitet in einer psychosomatischen Klinik und erh\u00e4lt Honorare f\u00fcr Lehr- und Fortbildungst\u00e4tigkeiten sowie f\u00fcr Supervision und Selbsterfahrung im Rahmen der \u00e4rztlichen und psychotherapeutischen Aus- und Weiterbildung.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Der Verlag erkl\u00e4rt, dass die inhaltliche Qualit\u00e4t des Beitrags durch zwei unabh\u00e4ngige Gutachten best\u00e4tigt wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere f\u00fcr Pr\u00e4parate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}